- Published at
- by gurufocus.com
positive
positive
Pfizer Inc (PFE) Gains FDA Approval for ADCETRIS Combination Therapy in Treating Large B-Cell Lymphoma
Pfizer Inc (PFE) announced on February 12, 2025, that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (s